Real-time enrollment status for this melanoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 8:07 AM UTC
| NCT Number | NCT06743126 |
| Recruiting Status | Recruiting |
| Condition | Melanoma |
| Phase | PHASE3 |
| Target Enrollment | 360 participants |
| Active Locations | 40 sites in the US |
| Sponsor | Immatics US, Inc. |
| Last Updated on CT.gov | June 10, 2026 (Jun 10, 2026) |
As of July 18, 2026: Clinical trial NCT06743126 is currently recruiting participants. This phase3 study for melanoma is actively seeking new participants at 40 locations across the United States. The study is sponsored by Immatics US, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06743126 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 40 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06743126 was last updated Jun 10, 2026 (June 10, 2026). HelloStudys verifies this status automatically.